Liver Transporters in Hepatic Drug Disposition: An Update

By  

Current Drug Metabolism, Vol. 10, Iss. 5, 2009-06 ,pp. : 482-498

Bentham Science Publishers

Access to resources Recommend Favorite

Effects on drug disposition, brain monoamines and behavior after chronic treatment with the antidepressant venlafaxine in rats with experimental hepatic encephalopathy

By Wikell C.   Apelqvist G.   Hjorth S.   Kullingsjo J.   Bergqvist P.B.F.   Bengtsson F.  

European Neuropsychopharmacology, Vol. 12, Iss. 4, 2002-08 ,pp. : 327-336

Elsevier

Access to resources Recommend Favorite

A Semi-Mechanistic Model to Predict the Effects of Liver Cirrhosis on Drug Clearance

By Johnson Trevor N.   Boussery Koen   Rowland-Yeo Karen   Tucker Geoffrey T.   Rostami-Hodjegan Amin  

Clinical Pharmacokinetics, Vol. 49, Iss. 3, 2010-03 ,pp. : 189-206

Adis International

Access to resources Recommend Favorite

Methodologies for Investigating Drug Metabolism at the Early Drug Discovery Stage: Prediction of Hepatic Drug Clearance and P450 Contribution

By  

Current Drug Metabolism, Vol. 11, Iss. 8, 2010-10 ,pp. : 678-685

Bentham Science Publishers

Access to resources Recommend Favorite

Hepatic Metabolic Clearance of Midazolam, a Cytochrome P450 3A Substrate, in the Presence of Ketoconazole in Rats

By Higashikawa F.   Murakami T.   Makino M.   Takano M.  

Pharmacy and Pharmacology Communications, Vol. 5, Iss. 8, 1999-08 ,pp. : 529-536

Pharmaceutical Press

Access to resources Recommend Favorite